Oncology
News
Drugs
Xagena Medicine
Xagena.net
Change in DNA repair gene MGMT may be underlying molecular defect in some colorectal cancers
Herceptin plus chemotherapy reduces risk of recurrence in early-stage HER2-positive breast cancer
Epigenetic activity silences Rb2/p130 gene in lung cancer and retinoblastoma cells
Plant extract may protect against liver cancer
Gamma-linolenic acid inhibits action of Her-2/neu, responsible for some breast cancers
Testicular carcinoma, fatherhood possible for many cancer survivors
TAP protein suppresses prostate cancer, enhances effects of vitamin E
Calcitriol and QW-1624-F2-2 are promising for prevention of androgen-dependent prostate cancer progression
FAK, an enzyme, could play a major role in promoting aggressive melanoma
Epithelial ovarian cancer, Topotecan plus Thalidomide more effective than Topotecan alone
Tumor immunization, a new approach to enhance the immune system in patients with cancer
Fused genes trigger the development of prostate cancer
Decline in breast cancer deaths explained by use of screening and adjuvant therapies
Psychological and social impacts of contralateral prophylactic mastectomy
Survival benefits of longer-term Tamoxifen therapy may take years to appear
Prostate cancer, identified how 1G8 antibody blocks growth in animal models
Integration of cell survival signals in PTEN-deficient tumors
TGFBR1*6A may represent a potential therapeutic target in cancer
Risk of breast cancer for young women treated for Hodgkin lymphoma
Three new genetic mutations in brain tumors identified
Juice of the pomegranate could combat prostate cancer
Family history may be the most effective measure for cancer risk
A molecular pathway that leads to recurrence of breast cancer discovered
Advanced non-small cell lung cancer, Tarceva benefits older patients
Gene MYC activates gene MTA1 involved in metastasis
Asthma, allergies may reduce risk of brain cancer
Microenvironment helps drive the breast cancer growth
Tarceva can prolong survival in patients with lung cancer
High levels of daily stress may reduce risk of breast cancer
Prostate cancer, some of the improvement in survival rates may be due to a shift in the classification
Next Pages
«
11
12
13
14
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions